Harman Finochem Limited — Allopurinol Exporter Profile
Indian Pharmaceutical Exporter · #6 for Allopurinol · $3.4M export value · DGFT Verified
Harman Finochem Limited is the #6 Indian exporter of Allopurinol with $3.4M in export value and 80 verified shipments. Harman Finochem Limited holds a 0.7% market share in Allopurinol exports across 4 countries. The company exports 3 pharmaceutical products worth $11.4M across 3 therapeutic categories.
Harman Finochem Limited — Allopurinol Export Profile: Buyers & Destinations
Where Does Harman Finochem Limited Export Allopurinol?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $1.0M | 32 | 38.9% |
| UNITED STATES | $964.3K | 30 | 35.8% |
| GERMANY | $538.4K | 15 | 20.0% |
| MALTA | $142.4K | 3 | 5.3% |
Harman Finochem Limited exports Allopurinol to 4 countries. The largest destination is UNITED KINGDOM accounting for 38.9% of Harman Finochem Limited's Allopurinol shipments, followed by UNITED STATES (35.8%) and GERMANY (20.0%). These destinations reflect Harman Finochem Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Allopurinol from Harman Finochem Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER | UNITED KINGDOM | $167.4K | 4 |
Harman Finochem Limited supplies Allopurinol to 1 buyers globally. The largest buyer is TO THE ORDER (UNITED KINGDOM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Allopurinol Export Value and How Much Does Harman Finochem Limited Contribute?
India exported $115.5M worth of Allopurinol through 4,362 shipments from 223 suppliers to 102 countries, serving 378 buyers globally. Harman Finochem Limited contributes $3.4M to this total, accounting for 0.7% of India's Allopurinol exports. Harman Finochem Limited ships Allopurinol to 4 countries through 1 buyers.
What Is the Average Shipment Value for Harman Finochem Limited's Allopurinol Exports?
Harman Finochem Limited's average Allopurinol shipment value is $42.5K per consignment, based on 80 shipments totaling $3.4M. The largest destination is UNITED KINGDOM (38.9% of Harman Finochem Limited's Allopurinol exports).
How Does Harman Finochem Limited Compare to Other Indian Allopurinol Exporters?
Harman Finochem Limited ranks #6 among 223 Indian Allopurinol exporters with a 0.7% market share. The top 3 exporters are INDOCO REMEDIES LIMITED ($34.1M), IPCA LABORATORIES LIMITED ($30.8M), UNICHEM LABORATORIES LIMITED ($22.2M). Harman Finochem Limited processed 80 shipments to 4 destination countries.
What Allopurinol Formulations Does Harman Finochem Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ALLOPURINOL 300MG TABLETS | $227.6K | 7 |
| ALLOPURINOL 300MG TABLETS (28)S | $199.8K | 4 |
| ALLOPURINOL 100MG TABLETS (28)S | $184.4K | 4 |
| ALLOPURINOL 100MG TABLETS | $130.7K | 4 |
| ALLOPURINOL 300MG TABLETSNOS | $100.2K | 4 |
| ALLOPURINOL 300MG TABLETS 28 S | $100.0K | 2 |
| Allopurinol Heumann 300mg Tab | $100.0K | 2 |
| Allopurinol Heumann 300mgTab 680 BOX PACKED ON 44 PALLETS | $100.0K | 2 |
| ALLOPURINOL TABLETS USP 100MG | $89.2K | 2 |
| ALLOPURINOL 100MG TABLETS (500)S | $81.8K | 3 |
Harman Finochem Limited exports 45 distinct Allopurinol formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ALLOPURINOL 300MG TABLETS with 7 shipments worth $227.6K.
Regulatory Requirements: Exporting Allopurinol to Key Markets
What Harman Finochem Limited must comply with to export Allopurinol to its top destination countries
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Germany — BfArM/EMA
Approval Process
Marketing Authorisation via Decentralized or Mutual Recognition Procedure under EU Directive 2001/83/EC. CTD Module 1–5 dossier required.
Timeline: 12–18 months via Decentralized Procedure
GMP & Export Requirements
EU GMP (EudraLex Vol. 4); GMP certificate from EU competent authority; WHO Prequalification accepted as supporting evidence
Certificate of Pharmaceutical Product (CPP) from CDSCO; Written Confirmation for API export per EU requirements; EU FMD serialization mandatory
Note: Indian manufacturers must hold EU GMP certificate. EU Falsified Medicines Directive (FMD) serialization and tamper-evident packaging mandatory.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Harman Finochem Limited Compare to Nearest Allopurinol Exporters?
Exporters ranked immediately above and below #6 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | PAR FORMULATIONS PRIVATE LIMITED | $10.6M | 211 | 1 | $50.0K |
| 4 | SANDOZ PRIVATE LIMITED | $4.8M | 97 | 2 | $50.0K |
| 6 | HARMAN FINOCHEM LIMITED ★ | $3.4M | 80 | 4 | $42.5K |
| 7 | ZYDUS LIFESCIENCES LIMITED | $2.7M | 55 | 1 | $48.3K |
| 8 | CAPLIN POINT LABORATORIES LIMITED | $1.6M | 90 | 6 | $18.2K |
Harman Finochem Limited ranks #6 among 223 Indian Allopurinol exporters. Average shipment value of $42.5K compared to the market average of $517.9K. The closest competitors by value are PAR FORMULATIONS PRIVATE LIMITED and SANDOZ PRIVATE LIMITED.
Which Indian Ports Ship Allopurinol Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 724 | 16.6% |
| SAHAR AIR | 501 | 11.5% |
| JNPT/ NHAVA SHEVA SEA | 446 | 10.2% |
| SAHAR AIR CARGO ACC (INBOM4) | 380 | 8.7% |
| DELHI AIR CARGO ACC (INDEL4) | 308 | 7.1% |
| JNPT | 261 | 6.0% |
| DELHI AIR | 203 | 4.7% |
| NHAVA SHEVA SEA | 134 | 3.1% |
Geopolitical & Trade Policy Impact on Harman Finochem Limited's Allopurinol Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Harman Finochem. The Israel-Iran conflict has led to disruptions in the Red Sea shipping routes, causing increased shipping costs and delays. These maritime disruptions have particularly impacted time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and supply chain management. (pharmaceuticalcommerce.com)
In the United States, recent tariff escalations have introduced additional complexities. The imposition of 100% tariffs on branded or patented pharmaceutical products from India, effective October 1, 2025, poses a significant challenge. While generic drugs may remain largely unaffected, the overall trade environment has become more volatile, requiring exporters to reassess their market strategies. (itisbl.com)
Conversely, the India-European Union Free Trade Agreement, signed on January 27, 2026, offers a positive development. The agreement eliminates tariffs on most European pharmaceutical exports to India and vice versa, potentially enhancing market access and competitiveness for Indian exporters in the EU market. (en.wikipedia.org)
Harman Finochem Limited — Regulatory Compliance & Quality Standards
The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with stringent quality and compliance standards becoming the norm. For Indian exporters, adherence to FDA, WHO, and EU Good Manufacturing Practices (GMP) is imperative to maintain market access. Companies with robust quality systems and proactive compliance cultures are better positioned to navigate this landscape. Smaller players may face challenges due to rising compliance costs, potentially leading to industry consolidation. (lupinnews.com)
While specific regulatory events involving Harman Finochem are not detailed in the available sources, the company's sustained export performance suggests a commitment to maintaining high-quality standards. Continuous investment in quality assurance and compliance infrastructure will be crucial for sustaining and expanding its export footprint.
About Harman Finochem Limited
Harman Finochem Limited exports 3 products worth $11.4M. Beyond Allopurinol, top products include Metformin, Bisoprolol. View the complete Harman Finochem Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Allopurinol — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Allopurinol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Harman Finochem Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 80 individual customs records matching Harman Finochem Limited exporting Allopurinol, covering 45 formulations to 4 countries via 1 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 102+ countries, 378+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Allopurinol Export Data from Harman Finochem Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Harman Finochem Limited's Allopurinol exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Harman Finochem Limited
Full Company Profile →
3 products · $11.4M total trade · 3 categories
Allopurinol Stats
Company Overview
Top Products by Harman Finochem Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Harman Finochem Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Allopurinol. For current shipment-level data, contact TransData Nexus.